These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9416311)

  • 1. Tumor specific contrast enhancement study of Mn-metalloporphyrin (ATN-10)--comparison of rat brain tumor model, cytotoxic and vasogenic edema models.
    Fujimori H; Matsumura A; Yamamoto T; Shibata Y; Yoshizawa T; Nakagawa K; Yoshii Y; Nose T; Sakata I; Nakajima S
    Acta Neurochir Suppl; 1997; 70():167-9. PubMed ID: 9416311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese-metalloporphyrin (ATN-10) as a tumor-localizing agent: magnetic resonance imaging and inductively coupled plasma atomic emission spectroscopy study with experimental brain tumors.
    Yamamoto T; Matsumura A; Shibata Y; Fujimori H; Nakai K; Yoshida F; Nose T; Sakata I; Nakajima S; Miwa N
    Neurosurgery; 1998 Jun; 42(6):1332-7; discussion 1337-8. PubMed ID: 9632193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective enhancement of experimental rat brain tumors with Gd-TPPS.
    Bockhorst K; Els T; Hoehn-Berlage M
    J Magn Reson Imaging; 1994; 4(3):451-6. PubMed ID: 8061446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging.
    Matsumura A; Shibata Y; Yamamoto T; Nakagawa K; Yasuda S; Nakajima S; Sakata I; Yoshizawa T; Nose T
    Neurol Med Chir (Tokyo); 1997 Apr; 37(4):327-31. PubMed ID: 9136556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI contrast enhancement by Gd-DTPA-monoclonal antibody in 9L glioma rats.
    Matsumura A; Shibata Y; Nakagawa K; Nose T
    Acta Neurochir Suppl (Wien); 1994; 60():356-8. PubMed ID: 7976589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyke Award Paper. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR.
    Schmiedl UP; Kenney J; Maravilla KR
    AJNR Am J Neuroradiol; 1992; 13(1):5-14. PubMed ID: 1595491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H; Enmi J; Teramoto N; Hayashi T; Yamamoto A; Tsuji T; Naito H; Iida H
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent.
    Runge VM; Kaufman DM; Wood ML; Adelman LS; Jacobson S
    Int J Rad Appl Instrum B; 1989; 16(6):561-7. PubMed ID: 2606711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI characterization of 9L-glioma in rat brain at 4.7 Tesla.
    Rajan SS; Rosa L; Francisco J; Muraki A; Carvlin M; Tuturea E
    Magn Reson Imaging; 1990; 8(2):185-90. PubMed ID: 2338899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mn[III] uroporphyrin I: a novel metalloporphyrin contrast agent for magnetic resonance imaging.
    McMillan JH; Cox GG; Kimler BF; Spicer JS; Batnitzky S
    Magn Reson Imaging; 1991; 9(4):553-8. PubMed ID: 1779726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhancement of PC-3 prostate cancer for magnetic resonance imaging: animal studies using tumor-localizing Mn-metalloporphyrin (THF-Mn-Asp).
    Suzuki T; Nakano K; Tomiyoshi K; Sakata I; Endo K; Yamanaka H
    J Urol; 1996 Nov; 156(5):1850-2. PubMed ID: 8863630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-enhancement effect of a Mn3+ metalloporphyrin derivative (ATN-4T) in magnetic resonance imaging.
    Kobayashi M; Tajiri H; Hayashi T; Kuroki M; Sakata I
    Cancer Lett; 1999 Mar; 137(1):83-9. PubMed ID: 10376797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vivo.
    Norman AB; Thomas SR; Pratt RG; Samaratunga RC; Sanberg PR
    Brain Res; 1989 Nov; 503(1):156-9. PubMed ID: 2611648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
    Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
    Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA.
    Liu X; Madhankumar AB; Miller PA; Duck KA; Hafenstein S; Rizk E; Slagle-Webb B; Sheehan JM; Connor JR; Yang QX
    Neuro Oncol; 2016 May; 18(5):691-9. PubMed ID: 26519740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105.
    Zhang D; Feng XY; Henning TD; Wen L; Lu WY; Pan H; Wu X; Zou LG
    Eur J Radiol; 2009 Apr; 70(1):180-9. PubMed ID: 18541399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.
    Bagga P; Haris M; D'Aquilla K; Wilson NE; Marincola FM; Schnall MD; Hariharan H; Reddy R
    J Transl Med; 2017 May; 15(1):119. PubMed ID: 28558795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.